Neil L. Berinstein

4.1k total citations
104 papers, 2.9k citations indexed

About

Neil L. Berinstein is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Neil L. Berinstein has authored 104 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 44 papers in Pathology and Forensic Medicine and 43 papers in Oncology. Recurrent topics in Neil L. Berinstein's work include Lymphoma Diagnosis and Treatment (44 papers), Immunotherapy and Immune Responses (33 papers) and Chronic Lymphocytic Leukemia Research (21 papers). Neil L. Berinstein is often cited by papers focused on Lymphoma Diagnosis and Treatment (44 papers), Immunotherapy and Immune Responses (33 papers) and Chronic Lymphocytic Leukemia Research (21 papers). Neil L. Berinstein collaborates with scholars based in Canada, United States and France. Neil L. Berinstein's co-authors include Brian H. Barber, Ronald Levy, Akiko Iwasaki, Amanda Chan, Rena Buckstein, Isabelle Bence‐Bruckler, Diying Shen, Christine A. White, David G. Maloney and A.J. Grillo-López and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Neil L. Berinstein

101 papers receiving 2.8k citations

Peers

Neil L. Berinstein
T C Meeker United States
Fumiko Arakawa Japan
James E. Wooldridge United States
Dirk Nagorsen United States
Maurizio Bendandi Italy
S Poppema Netherlands
Ichiro Kubonishi Japan
M. Schaadt Germany
Bernard Mariamé France
Joshua Brody United States
T C Meeker United States
Neil L. Berinstein
Citations per year, relative to Neil L. Berinstein Neil L. Berinstein (= 1×) peers T C Meeker

Countries citing papers authored by Neil L. Berinstein

Since Specialization
Citations

This map shows the geographic impact of Neil L. Berinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil L. Berinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil L. Berinstein more than expected).

Fields of papers citing papers by Neil L. Berinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil L. Berinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil L. Berinstein. The network helps show where Neil L. Berinstein may publish in the future.

Co-authorship network of co-authors of Neil L. Berinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Neil L. Berinstein. A scholar is included among the top collaborators of Neil L. Berinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil L. Berinstein. Neil L. Berinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rashedi, Iran, Kathryn Mangoff, Gail Klein, et al.. (2024). Intensity of survivin expression linked to features of aggressive relapsed/refractory diffuse large B-cell lymphoma. Leukemia & lymphoma. 66(1). 84–94. 1 indexed citations
3.
Berinstein, Neil L., Kees-Peter de Roos, Rebecca F. McClure, et al.. (2023). Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM). Hematological Oncology. 41(S2). 396–397. 1 indexed citations
4.
Wolf, Gregory T., Jeffrey S. Moyer, Michael J. Kaplan, et al.. (2018). IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers. OncoTargets and Therapy. Volume 11. 3731–3746. 18 indexed citations
5.
Wolf, Gregory T., Jason G. Newman, Neil L. Berinstein, et al.. (2017). Immune profile analysis of head and neck squamous cell carcinoma before and after neoadjuvant treatment with the IRX-2 regimen. Annals of Oncology. 28. v380–v381. 1 indexed citations
6.
Weir, Genevieve, Marianne M. Stanford, Neil L. Berinstein, et al.. (2014). Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response. OncoImmunology. 3(8). e953407–e953407. 29 indexed citations
7.
Cheung, Matthew C., Eugenia Piliotis, David Spaner, et al.. (2014). Survival of patients with transformed lymphoma in the rituximab era. Annals of Hematology. 93(6). 1007–1014. 27 indexed citations
8.
Berinstein, Neil L., Gregory T. Wolf, Paul H. Naylor, et al.. (2011). Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen. Cancer Immunology Immunotherapy. 61(6). 771–782. 35 indexed citations
9.
Chen, Jie Qing, Li Xiao, Hua-Zhong Zhang, et al.. (2010). Quantitative Immunohistochemical Analysis and Prognostic Significance of TRPS-1, a New GATA Transcription Factor Family Member, in Breast Cancer. Hormones and Cancer. 1(1). 21–33. 38 indexed citations
10.
Hicks, Lisa K., Rena Buckstein, Joy Mangel, et al.. (2008). Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma. Bone Marrow Transplantation. 43(9). 701–708. 56 indexed citations
11.
Bos, Rinke, Suzanne van Duikeren, Thorbald van Hall, et al.. (2007). Characterization of Antigen-Specific Immune Responses Induced by Canarypox Virus Vaccines. The Journal of Immunology. 179(9). 6115–6122. 19 indexed citations
12.
Berinstein, Neil L.. (2006). Principles of maintenance therapy. Leukemia Research. 30. S3–S10. 10 indexed citations
13.
Guinn, Barbara‐ann, et al.. (2005). Bcl-2 and c-Myc co-operate in the Epstein – Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity. Leukemia & lymphoma. 46(4). 581–592. 2 indexed citations
14.
15.
Berinstein, Neil L. & Joy Mangel. (2004). Integrating Monoclonal Antibodies into the Management of Mantle Cell Lymphoma. Seminars in Oncology. 31(1 Suppl 2). 2–6. 10 indexed citations
16.
Mangel, Joy, Rena Buckstein, Kevin Imrie, et al.. (2002). Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Seminars in Oncology. 29(1). 56–69. 46 indexed citations
17.
Zarrin, Ali A., et al.. (1999). Comparison of CMV, RSV, SV40 viral and Vλ1 cellular promoters in B and T lymphoid and non-lymphoid cell lines. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1446(1-2). 135–139. 42 indexed citations
18.
Berinstein, Neil L., A.J. Grillo-López, Christine A. White, et al.. (1998). Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma. Annals of Oncology. 9(9). 995–1001. 444 indexed citations
19.
Piovesan, Beata, Nancy Pennell, & Neil L. Berinstein. (1998). Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity. Oncogene. 17(18). 2339–2350. 21 indexed citations
20.
Chu, Nina, Teresa S. Hawley, Brian H. Barber, et al.. (1997). Enhanced Immunogenicity of B Cell Lymphoma Genetically Engineered to Express Both B7-1 and Interleukin-12. Human Gene Therapy. 8(18). 2217–2228. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T C Meeker Breakdown of academic impact, for papers by Fumiko Arakawa Breakdown of academic impact, for papers by James E. Wooldridge Breakdown of academic impact, for papers by Dirk Nagorsen Breakdown of academic impact, for papers by Maurizio Bendandi Breakdown of academic impact, for papers by S Poppema Breakdown of academic impact, for papers by Ichiro Kubonishi Breakdown of academic impact, for papers by M. Schaadt Breakdown of academic impact, for papers by Bernard Mariamé Breakdown of academic impact, for papers by Joshua Brody
Rankless by CCL
2026